SB

SB Bioscience is a South Korean private biotech company developing aptamer-based platforms for diagnostics and drug discovery. The company focuses on discovering aptamers that can be used alongside antibodies, enabling sandwich-assay diagnostics, signal amplification technologies for lateral flow assays and ELISA, and potential bio-better therapeutic applications. Its disclosed commercial and near-commercial activity appears to center on diagnostic reagents, assay development, laboratory products, and research services rather than advanced clinical-stage therapeutics. SB Bioscience also offers contract services such as aptamer selection, antibody analysis, protein expression, and related R&D support. The company positions itself as a platform-driven life sciences business spanning diagnostics, reagent distribution, and early-stage new drug research.